- Lois et règlements
- eservices
-
Media Center
Hotline for Health Services for Displaced Lebanese 1787Hotline for the Patient Admission to Hospitals 01/832700COVID-19 Vaccine Registration Form covax.moph.gov.lbMoPH Hotline 1214
Are you a new member? Sign up now
close
ENTYVIO - 300mg - 1
| ATC | B/G | Ingredients | code | Registration Nb | brand_name | Dosage | Presentation | Form | Route | Agent | Laboratory | man_country | Price | Pharmacist Margin | Startum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L04AA33 | BioTech | Vedolizumab - 300mg | 8398 | 122615/1 | ENTYVIO | 300mg | 1 | Injectable powder for concentrate for solution | Infusion | Century Pharma SAL | Takeda Austria GmbH | Austria | 152,492,033 L.L | 2.44 | E2 | Takeda Pharma AS | Denmark | 2/5/2024 | 0 |